—Social game maker Zynga has reportedly lost its COO, CTO and head of HR as a part of a restructuring being done by CEO Don Mattrick, according to a new report by AllThingsD. Chief Operating Officer David Ko, Chief Technical Officer Cadir Lee and Chief People Officer Colleen McCreary are all reported to be stepping down from their posts in the C-suite and leaving the company at the behest of Mattrick, who left his position as the head of Microsoft’s Xbox division to helm the ailing social game maker. The news comes after a companywide layoff at Zynga earlier this summer.
–Spencer Lee has joined Julep Beauty as its Chief Financial Officer. Before joining Julep, Lee served as the CFO for Demand Media’s Registrar Services division. “As a rapidly growing multi-channel e-commerce company, we are excited to welcome an executive like Spencer who is able to navigate fluidly and insightfully between high level strategy and granular data,” Julep founder and CEO Jane Park said in a press release. “His deep experience in finance and digital commerce will be a boon for Julep as we continue on our path of exponential growth.” Julep earlier this year raised $15.3 million in venture funding from Maveron, the venture capital firm founded by Starbucks Chairman Howard Schultz, and Andreessen Horowtiz.
–Scott Jones was hired by Tableau Software as the company’s Vice President of Americas Sales, according to the company’s Q2 earnings report. Jones spent the past 11 years at SAP, where he most recently served as the Chief Operations Officer of the company’s Database and Technology division.
–Bob More will be joining the Bill and Melinda Gates Foundation as a senior advisor for venture investing, reports Xconomy. More, who was previously a partner with Frazier Healthcare Ventures and Domain Associates, will now be helping to build a venture capital program at the Gates Foundation to support entrepreneurs whose companies are in line with the Foundation’s mission. In a letter to friends and colleagues about the move, More said that he was “hopeful” about the impact his work with the foundation would have.”Using venture capital as a tool to support entrepreneurs in their mission to address challenges in science and healthcare is a small part of what the Foundation does, but I am hopeful that it can make a big difference,” he said. The former Chief Operating Officer of Small Molecule Therapeutics joined Frazier in 2008.
–Michael A. Jacobsen is joining biopharmaceutical company Omeros as its Vice President of Finance and Chief Accounting Officer. Previously, Jacobsen was the Vice President of Finance and Chief Accounting Officer at Sarepta Theraputics. “Mike’s experience leading finance teams responsible for the commercial launch of biopharmaceutical products including Cialis, one of the most successful drugs on the market, will be instrumental as we anticipate marketing approval for OMS302 next year,” Omeros’s Chairman and CEO Gregory A. Demopulos told Benzinga.